BIO Historical Financial Ratios

BKYI Stock

USD 0.90 0.02 2.17%

BIO Key is presently reporting on over 109 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0028, PTB Ratio of 1.66 or Days Sales Outstanding of 92.33 will help investors to properly organize and evaluate BIO Key International financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

About BIO Financial Ratios Analysis

BIO Key InternationalFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate BIO Key investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on BIO financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across BIO Key history.

BIO Key Financial Ratios Chart

As of now, BIO Key's Book Value Per Share is increasing as compared to previous years. The BIO Key's current Average Payables is estimated to increase to about 1.3 M, while Price To Sales Ratio is projected to decrease to 0.21.

Price To Sales Ratio Dividend Yield Average Payables Days Payables Outstanding

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing BIO Key International stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on BIO Key sales, a figure that is much harder to manipulate than other BIO Key International multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is BIO Key International dividend as a percentage of BIO Key stock price. BIO Key International dividend yield is a measure of BIO Key stock productivity, which can be interpreted as interest rate earned on an BIO Key investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Most ratios from BIO Key's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into BIO Key International current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

	2023	2024 (projected)
Dividend Yield	0.002682	0.002817
Price To Sales Ratio	0.22	0.21

Dividend Yield Price To Sales Ratio

BIO Key fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding
Price To Sales Ratio		-0.8	-1.0	-0.56	-0.18	0.17	-0.13	-0.45	0.41	-1.0	1.0	-0.15	-0.06	-0.17	0.04	0.88	-0.26	-0.24	1.0	-0.1	-0.47	0.14	0.82	-0.25	-0.45	0.99
Dividend Yield	-0.8		0.77	0.36	0.25	-0.35	-0.05	0.43	-0.66	0.77	-0.8	-0.04	0.21	-0.17	-0.29	-0.59	0.55	0.65	-0.8	0.27	0.19	0.05	-0.8	0.18	0.18	-0.85
Ptb Ratio	-1.0	0.77		0.55	0.17	-0.15	0.14	0.4	-0.39	1.0	-1.0	0.17	0.05	0.16	-0.02	-0.89	0.26	0.2	-0.99	0.09	0.43	-0.2	-0.82	0.27	0.41	-0.99
Days Sales Outstanding	-0.56	0.36	0.55		0.44	0.14	-0.05	0.2	-0.43	0.55	-0.56	-0.03	-0.22	-0.22	0.26	-0.52	0.37	-0.03	-0.57	0.07	0.14	-0.26	-0.47	0.17	0.12	-0.57
Book Value Per Share	-0.18	0.25	0.17	0.44		0.05	-0.44	0.07	-0.31	0.17	-0.18	-0.43	-0.41	-0.35	0.16	0.01	0.11	0.22	-0.19	0.84	-0.06	0.04	-0.24	0.3	-0.06	-0.2
Free Cash Flow Yield	0.17	-0.35	-0.15	0.14	0.05		0.07	-0.78	0.41	-0.15	0.17	0.06	0.1	0.25	0.04	0.07	-0.12	-0.64	0.19	0.05	0.01	-0.32	0.46	-0.49	0.01	0.21
Operating Cash Flow Per Share	-0.13	-0.05	0.14	-0.05	-0.44	0.07		-0.07	0.38	0.14	-0.13	1.0	-0.33	0.59	0.47	-0.35	0.26	-0.38	-0.11	-0.52	0.27	-0.4	0.05	-0.55	0.28	-0.1
Average Payables	-0.45	0.43	0.4	0.2	0.07	-0.78	-0.07		-0.37	0.4	-0.45	-0.05	-0.05	0.01	-0.04	-0.39	-0.01	0.4	-0.47	0.04	0.32	0.38	-0.51	0.47	0.31	-0.46
Capex To Depreciation	0.41	-0.66	-0.39	-0.43	-0.31	0.41	0.38	-0.37		-0.39	0.41	0.37	-0.17	0.6	0.28	0.24	-0.51	-0.63	0.45	-0.23	0.28	0.2	0.59	-0.48	0.29	0.51
Pb Ratio	-1.0	0.77	1.0	0.55	0.17	-0.15	0.14	0.4	-0.39		-1.0	0.17	0.05	0.16	-0.02	-0.89	0.26	0.2	-0.99	0.09	0.43	-0.2	-0.82	0.27	0.41	-0.99
Ev To Sales	1.0	-0.8	-1.0	-0.56	-0.18	0.17	-0.13	-0.45	0.41	-1.0		-0.15	-0.06	-0.17	0.04	0.88	-0.26	-0.24	1.0	-0.1	-0.47	0.14	0.82	-0.25	-0.45	0.99
Free Cash Flow Per Share	-0.15	-0.04	0.17	-0.03	-0.43	0.06	1.0	-0.05	0.37	0.17	-0.15		-0.33	0.59	0.47	-0.37	0.26	-0.37	-0.13	-0.51	0.28	-0.4	0.03	-0.54	0.29	-0.13
Roic	-0.06	0.21	0.05	-0.22	-0.41	0.1	-0.33	-0.05	-0.17	0.05	-0.06	-0.33		-0.13	-0.94	-0.1	-0.06	0.19	-0.07	-0.02	0.0	0.14	-0.11	0.1	-0.01	-0.08
Inventory Turnover	-0.17	-0.17	0.16	-0.22	-0.35	0.25	0.59	0.01	0.6	0.16	-0.17	0.59	-0.13		0.27	-0.33	-0.33	-0.53	-0.14	-0.25	0.68	-0.05	0.2	-0.41	0.68	-0.08
Net Income Per Share	0.04	-0.29	-0.02	0.26	0.16	0.04	0.47	-0.04	0.28	-0.02	0.04	0.47	-0.94	0.27		0.05	0.06	-0.38	0.05	-0.27	0.07	-0.24	0.16	-0.22	0.08	0.07
Days Of Inventory On Hand	0.88	-0.59	-0.89	-0.52	0.01	0.07	-0.35	-0.39	0.24	-0.89	0.88	-0.37	-0.1	-0.33	0.05		-0.26	0.05	0.88	0.0	-0.46	0.22	0.68	-0.09	-0.44	0.86
Payables Turnover	-0.26	0.55	0.26	0.37	0.11	-0.12	0.26	-0.01	-0.51	0.26	-0.26	0.26	-0.06	-0.33	0.06	-0.26		0.25	-0.27	-0.05	-0.13	-0.32	-0.45	-0.23	-0.13	-0.35
Average Inventory	-0.24	0.65	0.2	-0.03	0.22	-0.64	-0.38	0.4	-0.63	0.2	-0.24	-0.37	0.19	-0.53	-0.38	0.05	0.25		-0.26	0.29	-0.08	0.33	-0.54	0.47	-0.09	-0.31
Capex To Revenue	1.0	-0.8	-0.99	-0.57	-0.19	0.19	-0.11	-0.47	0.45	-0.99	1.0	-0.13	-0.07	-0.14	0.05	0.88	-0.27	-0.26		-0.1	-0.44	0.15	0.83	-0.28	-0.42	0.99
Cash Per Share	-0.1	0.27	0.09	0.07	0.84	0.05	-0.52	0.04	-0.23	0.09	-0.1	-0.51	-0.02	-0.25	-0.27	0.0	-0.05	0.29	-0.1		-0.02	0.21	-0.17	0.29	-0.03	-0.12
Pocfratio	-0.47	0.19	0.43	0.14	-0.06	0.01	0.27	0.32	0.28	0.43	-0.47	0.28	0.0	0.68	0.07	-0.46	-0.13	-0.08	-0.44	-0.02		0.12	-0.37	0.08	1.0	-0.39
Interest Coverage	0.14	0.05	-0.2	-0.26	0.04	-0.32	-0.4	0.38	0.2	-0.2	0.14	-0.4	0.14	-0.05	-0.24	0.22	-0.32	0.33	0.15	0.21	0.12		0.09	0.04	0.13	0.18
Payout Ratio	0.82	-0.8	-0.82	-0.47	-0.24	0.46	0.05	-0.51	0.59	-0.82	0.82	0.03	-0.11	0.2	0.16	0.68	-0.45	-0.54	0.83	-0.17	-0.37	0.09		-0.54	-0.35	0.86
Capex To Operating Cash Flow	-0.25	0.18	0.27	0.17	0.3	-0.49	-0.55	0.47	-0.48	0.27	-0.25	-0.54	0.1	-0.41	-0.22	-0.09	-0.23	0.47	-0.28	0.29	0.08	0.04	-0.54		0.07	-0.28
Pfcf Ratio	-0.45	0.18	0.41	0.12	-0.06	0.01	0.28	0.31	0.29	0.41	-0.45	0.29	-0.01	0.68	0.08	-0.44	-0.13	-0.09	-0.42	-0.03	1.0	0.13	-0.35	0.07		-0.37
Days Payables Outstanding	0.99	-0.85	-0.99	-0.57	-0.2	0.21	-0.1	-0.46	0.51	-0.99	0.99	-0.13	-0.08	-0.08	0.07	0.86	-0.35	-0.31	0.99	-0.12	-0.39	0.18	0.86	-0.28	-0.37

Click cells to compare fundamentals

BIO Key Account Relationship Matchups

BIO Key fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	3.14	5.83	3.37	0.68	0.22	0.21
Ptb Ratio	(3.11)	0.81	1.11	0.67	1.58	1.66
Days Sales Outstanding	38.14	116.25	78.65	81.75	61.23	92.33
Book Value Per Share	(23.14)	77.87	35.99	15.69	1.9	1.99
Free Cash Flow Yield	(0.26)	(0.3)	(0.52)	(1.33)	(2.26)	(2.14)
Operating Cash Flow Per Share	(18.73)	(18.95)	(20.74)	(13.84)	(6.77)	(7.11)
Stock Based Compensation To Revenue	0.42	0.28	0.0615	0.0553	0.0343	0.0326
Capex To Depreciation	0.0303	0.0833	0.0817	0.15	0.001695	0.00161
Pb Ratio	(3.11)	0.81	1.11	0.67	1.58	1.66
Ev To Sales	4.34	0.1	1.9	0.62	0.2	0.19
Free Cash Flow Per Share	(19.04)	(19.09)	(20.84)	(14.02)	(6.77)	(7.11)
Roic	221.78	(0.33)	(0.29)	(1.01)	(6.25)	(5.93)
Inventory Turnover	5.74	2.4	0.34	0.42	14.19	13.48
Net Income Per Share	(148.35)	(52.04)	(10.56)	(23.87)	(15.21)	(15.97)
Days Of Inventory On Hand	63.64	151.98	1.1K	865.16	25.73	24.44
Payables Turnover	2.68	3.26	3.91	1.84	4.81	5.05
Research And Ddevelopement To Revenue	0.35	0.59	0.49	0.46	0.31	0.29
Capex To Revenue	0.0134	0.0125	0.008217	0.0117	1.29E-4	1.23E-4
Cash Per Share	5.99	67.03	17.91	5.86	0.91	0.87
Pocfratio	(3.84)	(3.34)	(1.92)	(0.76)	(0.44)	(0.47)
Interest Coverage	(6.14)	(1.12)	(277.88)	(323.55)	(40.44)	(42.46)
Capex To Operating Cash Flow	(0.0165)	(0.007185)	(0.004681)	(0.0132)	(2.64E-4)	(2.77E-4)
Pfcf Ratio	(3.78)	(3.32)	(1.91)	(0.75)	(0.44)	(0.47)
Days Payables Outstanding	136.33	112.12	93.33	198.34	75.96	72.16
Income Quality	0.13	0.51	1.77	0.52	0.45	0.42
Roe	6.41	(0.67)	(0.29)	(1.52)	(8.01)	(7.61)
Ev To Operating Cash Flow	(5.32)	(0.0574)	(1.08)	(0.69)	(0.4)	(0.42)
Pe Ratio	(0.49)	(1.22)	(3.77)	(0.44)	(0.2)	(0.19)
Return On Tangible Assets	(6.46)	(0.69)	(0.3)	(1.06)	(2.74)	(2.88)
Ev To Free Cash Flow	(5.24)	(0.057)	(1.08)	(0.69)	(0.4)	(0.42)
Earnings Yield	(2.06)	(0.82)	(0.27)	(2.27)	(5.07)	(4.82)
Intangibles To Total Assets	0.6	0.0914	0.13	0.15	0.31	0.37
Net Debt To E B I T D A	(0.22)	3.32	1.65	0.0364	0.0186	0.0177
Tangible Book Value Per Share	(25.45)	67.01	29.96	11.68	(0.61)	(0.65)
Receivables Turnover	9.57	3.14	4.64	4.47	5.96	3.38

Currently Active Assets on Macroaxis

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft
HBI	Hanesbrands
STLD	Steel Dynamics

When determining whether BIO Key International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BIO Key's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Key International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Key International Stock:

How To Invest In BIO

Details

Is BIO Stock a good investment?

Details

What is BIO Key's Net Worth?

Details

Largest Systems Software Companies

View

Largest Security & Protection Services Companies

View

You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Is Systems Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(8.66)

Revenue Per Share

6.323

Quarterly Revenue Growth

(0.41)

Return On Assets

(0.56)

Return On Equity

(4.58)

The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

BIO Historical Financial Ratios

About BIO Financial Ratios Analysis

BIO Key Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Average Payables

BIO Key fundamentals Correlations

BIO Key Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BIO Key fundamentals Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Capex To Revenue	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Capex To Revenue	+ 1.0	Ev To Sales
Pfcf Ratio	+ 1.0	Pocfratio

Ev To Sales	- 1.0	Pb Ratio
Ev To Sales	- 1.0	Ptb Ratio
Pb Ratio	- 1.0	Price To Sales Ratio
Ptb Ratio	- 1.0	Price To Sales Ratio
Days Payables Outstanding	- 0.99	Pb Ratio
Capex To Revenue	- 0.99	Pb Ratio